Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The most common adverse events are gastrointestinal in nature, including nausea (20-47% depending on dose), constipation (21%), fatigue (20%), and vomiting (8%)
Multi-Dose Research Solution Preparation The solution enables preparation of multi-dose formulations usable over extended experimental periods
Most research peptides have favorable safety profiles in published studies
Commercial development was discontinued in 2007 after the Phase IIb trial failed to meet its primary endpoint
the choice often reflects the clinician's philosophy about peptide pharmacokinetics rather than direct comparative data
US$ 23.23
US$ 22.30
US$ 26.71
US$ 26.01
US$ 25.89
US$ 27.20
